Individual patient data meta-analysis and systematic review evaluating camostat mesilate to treat COVID-19
{{output}}
Background: In the COVID-19 pandemic, several phase II and III randomized trials were launched to evaluate the effectiveness of camostat, an orally administered TMPRSS2 inhibitor previously approved for other indications, for tre... ...
